Asset
ANAGRELIDE HYDROCHLORIDE
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT01214915 | phase3 | completed | 2010-10-27 | 2012-10-24 | Shire | Effect of SPD422 on Platelet Lowering and Safety in Japanese Adults With At Risk Essential Thrombocythaemia |
| NCT00413634 | phase2 | completed | 2006-11-13 | 2008-01-22 | Shire | The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 020333 | NDA | TAKEDA PHARMACEUTICALS USA INC |
Marketed products (2)
- AGRYLIN
- AGRYLIN